HEADER HYDROLASE(SERINE PROTEINASE) 14-JAN-91 9EST TITLE STRUCTURAL STUDY OF PORCINE PANCREATIC ELASTASE COMPLEXED WITH 7- TITLE 2 AMINO-3-(2-BROMOETHOXY)-4-CHLOROISOCOUMARIN AS A NONREACTIVATABLE TITLE 3 DOUBLY COVALENT ENZYME-INHIBITOR COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: PORCINE PANCREATIC ELASTASE; COMPND 3 CHAIN: A; COMPND 4 EC: 3.4.21.36; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SUS SCROFA; SOURCE 3 ORGANISM_COMMON: PIG; SOURCE 4 ORGANISM_TAXID: 9823 KEYWDS HYDROLASE(SERINE PROTEINASE) EXPDTA X-RAY DIFFRACTION AUTHOR R.RADHAKRISHNAN,J.C.POWERS,E.F.MEYER JR. REVDAT 4 07-JUL-10 9EST 1 AUTHOR REVDAT 3 24-FEB-09 9EST 1 VERSN REVDAT 2 01-APR-03 9EST 1 JRNL REVDAT 1 31-JAN-94 9EST 0 JRNL AUTH J.VIJAYALAKSHMI,E.F.MEYER JR.,C.M.KAM,J.C.POWERS JRNL TITL STRUCTURAL STUDY OF PORCINE PANCREATIC ELASTASE COMPLEXED JRNL TITL 2 WITH 7-AMINO-3-(2-BROMOETHOXY)-4-CHLOROISOCOUMARIN AS A JRNL TITL 3 NONREACTIVATABLE DOUBLY COVALENT ENZYME-INHIBITOR COMPLEX. JRNL REF BIOCHEMISTRY V. 30 2175 1991 JRNL REFN ISSN 0006-2960 JRNL PMID 1998677 JRNL DOI 10.1021/BI00222A022 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.A.HERNANDEZ,J.C.POWERS,J.GLINSKI,J.OLEKSYSZYN, REMARK 1 AUTH 2 J.VIJAYALAKSHMI,E.F.MEYERJUNIOR REMARK 1 TITL EFFECT OF THE 7-AMINO SUBSTITUENT ON THE INHIBITORY POTENCY REMARK 1 TITL 2 OF MECHANISM-BASED ISOCOUMARIN INHIBITORS FOR PORCINE REMARK 1 TITL 3 PANCREATIC AND HUMAN NEUTROPHIL ELASTASES: A 1.85-ANGSTROMS REMARK 1 TITL 4 X-RAY STRUCTURE OF THE COMPLEX BETWEEN PORCINE PANCREATIC REMARK 1 TITL 5 ELASTASE AND REMARK 1 TITL 6 7-[(N-TOSYLPHENYLALANYL)AMINO]-4-CHLORO-3-METHOXYISOCOUMARIN REMARK 1 REF J.MED.CHEM. V. 35 1121 1992 REMARK 1 REFN ISSN 0022-2623 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.C.POWERS,J.OLEKSYSZYN,S.L.NARASIMHAN,C.-M.KAM, REMARK 1 AUTH 2 R.RADHAKRISHNAN,E.F.MEYERJUNIOR REMARK 1 TITL REACTION OF PORCINE PANCREATIC ELASTASE WITH 7-SUBSTITUTED REMARK 1 TITL 2 3-ALKOXY-4-CHLOROISOCOUMARINS: DESIGN OF POTENT INHIBITORS REMARK 1 TITL 3 USING THE CRYSTAL STRUCTURE OF THE COMPLEX FORMED WITH REMARK 1 TITL 4 4-CHLORO-3-ETHOXY-7-GUANIDINO-ISOCOUMARIN REMARK 1 REF BIOCHEMISTRY V. 29 3108 1990 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.M.CHOW,E.F.MEYERJUNIOR,W.BODE,C.-M.KAM,R.RADHAKRISHNAN, REMARK 1 AUTH 2 J.VIJAYALAKSHMI,J.C.POWERS REMARK 1 TITL THE 2.2-ANGSTROM RESOLUTION X-RAY CRYSTAL STRUCTURE OF THE REMARK 1 TITL 2 COMPLEX OF TRYPSIN INHIBITED BY REMARK 1 TITL 3 4-CHLORO-3-ETHOXY-7-GUANIDINOISOCOUMARIN: A PROPOSED MODEL REMARK 1 TITL 4 OF THE THROMBIN-INHIBITOR COMPLEX REMARK 1 REF J.AM.CHEM.SOC. V. 112 7783 1990 REMARK 1 REFN ISSN 0002-7863 REMARK 1 REFERENCE 4 REMARK 1 AUTH W.BODE,E.F.MEYERJUNIOR,J.C.POWERS REMARK 1 TITL HUMAN LEUKOCYTE AND PORCINE PANCREATIC ELASTASE: X-RAY REMARK 1 TITL 2 CRYSTAL STRUCTURES, MECHANISM, SUBSTRATE SPECIFICITY, AND REMARK 1 TITL 3 MECHANISM-BASED INHIBITORS REMARK 1 REF BIOCHEMISTRY V. 28 1951 1989 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 5 REMARK 1 AUTH R.RADHAKRISHNAN,L.G.PRESTA,E.F.MEYERJUNIOR,R.WILDONGER REMARK 1 TITL CRYSTAL STRUCTURES OF THE COMPLEX OF PORCINE PANCREATIC REMARK 1 TITL 2 ELASTASE WITH TWO VALINE-DERIVED BENZOXAZINONE INHIBITORS REMARK 1 REF J.MOL.BIOL. V. 198 417 1987 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 6 REMARK 1 AUTH E.F.MEYERJUNIOR,L.G.PRESTA,R.RADHAKRISHNAN REMARK 1 TITL STEREOSPECIFIC REACTION OF REMARK 1 TITL 2 3-METHOXY-4-CHLORO-7-AMINO-ISOCOUMARIN WITH CRYSTALLINE REMARK 1 TITL 3 PORCINE PANCREATIC ELASTASE REMARK 1 REF J.AM.CHEM.SOC. V. 107 4091 1985 REMARK 1 REFN ISSN 0002-7863 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 11586 REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.171 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1822 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 22 REMARK 3 SOLVENT ATOMS : 133 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.010 ; NULL ; NULL REMARK 3 BOND ANGLES (DEGREES) : 1.120 ; NULL ; NULL REMARK 3 TORSION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES (A) : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : NULL ; NULL ; NULL REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : NULL REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9EST COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.56500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.72500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.07000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.72500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.56500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.07000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 195 O' IBR A 600 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 97 CB - CG - OD2 ANGL. DEV. = -5.7 DEGREES REMARK 500 ASP A 102 CB - CG - OD1 ANGL. DEV. = -6.3 DEGREES REMARK 500 ASP A 102 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 ASP A 164 CB - CG - OD1 ANGL. DEV. = 5.9 DEGREES REMARK 500 ASP A 164 CB - CG - OD2 ANGL. DEV. = -6.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 71 -56.85 -125.09 REMARK 500 ASN A 115 -163.12 -160.68 REMARK 500 TYR A 171 -117.13 -100.58 REMARK 500 SER A 214 -61.77 -107.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 727 DISTANCE = 5.11 ANGSTROMS REMARK 525 HOH A 885 DISTANCE = 5.29 ANGSTROMS REMARK 525 HOH A 891 DISTANCE = 5.16 ANGSTROMS REMARK 525 HOH A 902 DISTANCE = 5.13 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 THE BOND BETWEEN C1 AND O2 OF REMARK 600 7-*AMINO-3-(2-BROMOETHOXY)-4-CHLOROISOCOUMARIN HAS BEEN REMARK 600 BROKEN AND C4 (C2 OF IBR) IS NO LONGER BONDED TO CL BUT TO REMARK 600 NE2 OF HIS E 57. IN ADDITION, C' OF IBR IS COVALENTLY BOUND REMARK 600 TO OG OF SER 195. REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 325 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLN A 75 O REMARK 620 2 GLU A 80 OE2 97.1 REMARK 620 3 GLU A 70 OE1 152.2 109.9 REMARK 620 4 ASN A 77 ND2 97.5 95.8 74.0 REMARK 620 5 ASN A 72 O 77.9 173.8 74.7 81.2 REMARK 620 6 HOH A 327 O 93.1 73.9 100.3 166.1 109.9 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: CAT REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: NULL REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 510 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 325 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IBR A 600 REMARK 999 REMARK 999 SEQUENCE REMARK 999 SEQUENCE ADVISORY NOTICE: REMARK 999 DIFFERENCE BETWEEN SWISS-PROT AND PDB SEQUENCE. REMARK 999 REMARK 999 SWISS-PROT ENTRY NAME: EL1_PIG REMARK 999 REMARK 999 SWISS-PROT RESIDUE PDB SEQRES REMARK 999 NAME NUMBER NAME CHAIN SEQ/INSERT CODE REMARK 999 ASN 77 ASP 77 DBREF 9EST A 16 245 UNP P00772 ELA1_PIG 27 266 SEQADV 9EST ASN A 77 UNP P00772 ASP 92 CONFLICT SEQRES 1 A 240 VAL VAL GLY GLY THR GLU ALA GLN ARG ASN SER TRP PRO SEQRES 2 A 240 SER GLN ILE SER LEU GLN TYR ARG SER GLY SER SER TRP SEQRES 3 A 240 ALA HIS THR CYS GLY GLY THR LEU ILE ARG GLN ASN TRP SEQRES 4 A 240 VAL MET THR ALA ALA HIS CYS VAL ASP ARG GLU LEU THR SEQRES 5 A 240 PHE ARG VAL VAL VAL GLY GLU HIS ASN LEU ASN GLN ASN SEQRES 6 A 240 ASN GLY THR GLU GLN TYR VAL GLY VAL GLN LYS ILE VAL SEQRES 7 A 240 VAL HIS PRO TYR TRP ASN THR ASP ASP VAL ALA ALA GLY SEQRES 8 A 240 TYR ASP ILE ALA LEU LEU ARG LEU ALA GLN SER VAL THR SEQRES 9 A 240 LEU ASN SER TYR VAL GLN LEU GLY VAL LEU PRO ARG ALA SEQRES 10 A 240 GLY THR ILE LEU ALA ASN ASN SER PRO CYS TYR ILE THR SEQRES 11 A 240 GLY TRP GLY LEU THR ARG THR ASN GLY GLN LEU ALA GLN SEQRES 12 A 240 THR LEU GLN GLN ALA TYR LEU PRO THR VAL ASP TYR ALA SEQRES 13 A 240 ILE CYS SER SER SER SER TYR TRP GLY SER THR VAL LYS SEQRES 14 A 240 ASN SER MET VAL CYS ALA GLY GLY ASP GLY VAL ARG SER SEQRES 15 A 240 GLY CYS GLN GLY ASP SER GLY GLY PRO LEU HIS CYS LEU SEQRES 16 A 240 VAL ASN GLY GLN TYR ALA VAL HIS GLY VAL THR SER PHE SEQRES 17 A 240 VAL SER ARG LEU GLY CYS ASN VAL THR ARG LYS PRO THR SEQRES 18 A 240 VAL PHE THR ARG VAL SER ALA TYR ILE SER TRP ILE ASN SEQRES 19 A 240 ASN VAL ILE ALA SER ASN HET SO4 A 510 5 HET CA A 325 1 HET IBR A 600 16 HETNAM SO4 SULFATE ION HETNAM CA CALCIUM ION HETNAM IBR (2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE FORMUL 2 SO4 O4 S 2- FORMUL 3 CA CA 2+ FORMUL 4 IBR C11 H12 BR N O3 FORMUL 5 HOH *133(H2 O) HELIX 1 HA ASP A 164 SER A 170 1 7 HELIX 2 HB TYR A 234 ASN A 245 1HELICAL TAIL AT CARBOXY END 12 SHEET 1 A 7 SER A 29 SER A 36A 0 SHEET 2 A 7 SER A 37 ILE A 47 -1 SHEET 3 A 7 ASN A 50 ALA A 56 -1 SHEET 4 A 7 ASP A 102 GLN A 110 -1 SHEET 5 A 7 GLU A 80 HIS A 91 -1 SHEET 6 A 7 PHE A 65 GLY A 69 -1 SHEET 7 A 7 SER A 29 SER A 36A-1 SHEET 1 B 7 ASN A 133 THR A 144 0 SHEET 2 B 7 GLY A 149 VAL A 163 -1 SHEET 3 B 7 SER A 179 VAL A 188 -1 SHEET 4 B 7 ASN A 221 VAL A 231 -1 SHEET 5 B 7 HIS A 210 VAL A 216 -1 SHEET 6 B 7 SER A 195 CYS A 201 -1 SHEET 7 B 7 ASN A 133 THR A 144 -1 SHEET 1 C 3 GLY A 149 ALA A 152 0 SHEET 2 C 3 TRP A 141 LEU A 143 -1 SHEET 3 C 3 GLN A 192 ASP A 194 -1 SSBOND 1 CYS A 42 CYS A 58 1555 1555 2.02 SSBOND 2 CYS A 136 CYS A 201 1555 1555 2.00 SSBOND 3 CYS A 168 CYS A 182 1555 1555 1.97 SSBOND 4 CYS A 191 CYS A 220 1555 1555 2.06 LINK NE2 HIS A 57 C2 IBR A 600 1555 1555 1.47 LINK OG SER A 195 C' IBR A 600 1555 1555 1.32 LINK CA CA A 325 O GLN A 75 1555 1555 2.11 LINK CA CA A 325 OE2 GLU A 80 1555 1555 1.99 LINK CA CA A 325 OE1 GLU A 70 1555 1555 2.20 LINK CA CA A 325 ND2 ASN A 77 1555 1555 2.90 LINK CA CA A 325 O ASN A 72 1555 1555 2.40 LINK CA CA A 325 O HOH A 327 1555 1555 2.57 SITE 1 CAT 4 HIS A 57 ASP A 102 SER A 195 SER A 214 SITE 1 AC1 6 GLY A 127 ARG A 145 ARG A 230 SER A 232 SITE 2 AC1 6 ALA A 233 HOH A 801 SITE 1 AC2 6 GLU A 70 ASN A 72 GLN A 75 ASN A 77 SITE 2 AC2 6 GLU A 80 HOH A 327 SITE 1 AC3 9 THR A 41 CYS A 42 HIS A 57 CYS A 58 SITE 2 AC3 9 GLN A 192 GLY A 193 SER A 195 GLY A 196 SITE 3 AC3 9 SER A 214 CRYST1 51.130 58.140 75.450 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019558 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017200 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013254 0.00000